ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
360 patients around the world
Available in Puerto Rico, Spain, Colombia, United States, Mexico, Argentina, Brazil
Bristol-Myers Squibb
3Research sites
360Patients around the world
This study is for people with
Myelodysplastic Syndromes
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Británico de Buenos Aires - CABA
Recruiting
Perdriel 74, CABA, Buenos Aires
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires